Effective December 18, 2022 Stephen LaNeve resigned as a director of the Bone Biologics Corporation. The resignation was not the result of any disagreement with the Company on any matter relating to the Companyâs operations, policies, or practices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | +3.14% | +7.89% | -63.72% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.72% | 1.4M | |
+14.77% | 129B | |
-9.30% | 10.92B | |
-2.59% | 8.5B | |
+35.99% | 5.5B | |
-22.01% | 4.69B | |
+7.91% | 3.42B | |
-11.64% | 2.73B | |
-14.85% | 2B | |
-13.29% | 1.93B |
- Stock Market
- Equities
- BBLG Stock
- News Bone Biologics Corporation
- Bone Biologics Corporation Resigns Stephen Laneve as Director